SCHEMBL120841

SCHEMBL120841

COC(=O)c1ccc(S(=O)(=O)N(CCN2CCCCC2)c2ccc(C(F)(F)F)cc2Cl)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 3/20 0.49
RORC P51449 3/20 0.44
GLA P06280 2/20 0.43
ERAP1 Q9NZ08 2/20 0.42
ERAP2 Q6P179 1/20 0.42
CA12 O43570 1/20 0.42
CA9 Q16790 1/20 0.42
MMP3 P08254 1/20 0.41
KDM4E B2RXH2 2/20 0.40
MAPT P10636 2/20 0.40
CCR2 P41597 1/20 0.40
PSEN1 P49768 1/20 0.40
PSEN2 P49810 1/20 0.40
APH1B Q8WW43 1/20 0.40
NCSTN Q92542 1/20 0.40
APH1A Q96BI3 1/20 0.40
PSENEN Q9NZ42 1/20 0.40
ATM Q13315 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL119139 0.91 TRPM8 (0.60) TRPM8RORCCA12CA9MMP3
SCHEMBL123284 0.89 TRPM8 (0.61) TRPM8ERAP1
SCHEMBL121240 0.80 TRPM8 (0.74) TRPM8MMP3KDM4EALDH1A1
SCHEMBL118428 0.79 TRPM8 (0.60) TRPM8RORCKDM4EPSEN1PSEN2
SCHEMBL119634 0.77 TRPM8 (0.61) TRPM8RORCKDM4EPSEN1PSEN2
SCHEMBL118757 0.71 TRPM8 (0.69) TRPM8
SCHEMBL121220 0.70 TRPM8 (0.81) TRPM8
SCHEMBL119747 0.69 TRPM8 (0.79) TRPM8
SCHEMBL119180 0.68 TRPM8 (0.76) TRPM8
SCHEMBL117534 0.68 TRPM8 (0.79) TRPM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102427810-A Sulfamoylbenzoic acid derivatives as TRPM8 antagonists RAQUALIA PHARMA INC 2012-04-25 CN disclosed
US-20120094964-A1 SULFAMOYL BENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS RAQUALIA PHARMA INC. (JP) 2012-04-19 US disclosed
EP-2424517-A1 SULFAMOYL BENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS RaQualia Pharma Inc (JP) 2012-03-07 EP disclosed
WO-2010125831-A1 SULFAMOYL BENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS RAQUALIA PHARMA INC. (JP) 2010-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120094964-A1 SULFAMOYL BENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS TRPM8, TRPM5, TRPM6 TRPM8 1/4885RORC 1687/4885GLA 4002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.